Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
UBS
Fuji
McKinsey
Chinese Patent Office
Queensland Health
Covington
Healthtrust
Accenture
Medtronic

Generated: October 18, 2017

DrugPatentWatch Database Preview

Breckenridge Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?

BRECKENRIDGE PHARM has thirty approved drugs.



Summary for Applicant: Breckenridge Pharm

US Patents:0
Tradenames:25
Ingredients:25
NDAs:30
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge Pharm
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090870-001Mar 14, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
MELOXICAM
meloxicam
TABLET;ORAL077920-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077714-001Jun 4, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL207587-003Mar 3, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
SOLUTION;ORAL201466-002Nov 12, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
RABEPRAZOLE SODIUM
rabeprazole sodium
TABLET, DELAYED RELEASE;ORAL204237-001Nov 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
ZOLEDRONIC ACID
zoledronic acid
INJECTABLE;IV (INFUSION)091170-001Mar 4, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
METHSCOPOLAMINE BROMIDE
methscopolamine bromide
TABLET;ORAL040642-002Dec 6, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL207587-002Mar 3, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
PIOGLITAZONE HYDROCHLORIDE
pioglitazone hydrochloride
TABLET;ORAL078472-002Feb 13, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for BRECKENRIDGE PHARM drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cerilliant
Johnson and Johnson
Federal Trade Commission
Fish and Richardson
US Army
Mallinckrodt
Colorcon
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot